West Pharmaceutical Services Financials

Values in thousands	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Revenue	$766,200	$698,200	$748,500	$746,900
Gross Profit	273,200	232,700	274,400	265,200
EBITDA	198,500	150,900	205,600	205,400
EBIT	157,100	110,900	164,900	165,200
Net Income	131,800	89,800	130,100	136,000
Net Change In Cash	766,200	698,200	748,500	746,900
Free Cash Flow	101,900	58,100	85,200	98,800
Cash	509,700	404,200	484,600	490,900
Basic Shares	72,800	73,000	73,700	73,400

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,892,700	$2,951,100	$2,885,500	$2,830,700
Gross Profit	1,002,200	1,132,700	1,138,900	1,173,400
EBITDA	743,800	844,100	808,100	879,700
EBIT	588,400	706,800	687,500	757,400
Net Income	492,700	593,400	585,900	661,800
Net Change In Cash	2,892,700	2,951,100	2,885,500	2,830,700
Cost of Revenue			142,200	147,100
Free Cash Flow	276,400	414,500	439,400	330,600
Cash	484,600	853,900	894,300	762,600
Basic Shares	73,700	75,300	75,800	76,300